About Galileo
The project GALILEO steps in at an interesting point
Microfluidics is currently one of the strategies with the greatest potential to take cell testing and analysis for drug development to a new level. The success rate for drug candidates is still very low (around only 3.4% for cancer drugs), and conventional drug development still requires a lot of animal testing.
Integrated microscale fluidics offers radically new possibilities for in vitro cell cultures and opens the door to cutting-edge research in single cell analysis and nanotherapies. The further development of Microfluidics Innovation Center wide range flow sensor will be making an important contribution to this field of research.
As new as these approaches are, we see a lot of potential for technological developments in this area
End users report that the flow rate range they can measure and control with conventional sensors needs to be extended by a factor of 100. In addition, there is a need for high measurement accuracy and sensor drift detection in order to minimize experimental errors.
The GALILEO project tackles these urgent requirements for diagnosis, drug discovery and development by developing a novel wide range flow sensor. The project will contribute to improving the success rate of new therapeutics and help provide earlier detection and treatment.